Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
J.S. Held Recognized Among Global Leaders in Enterprise Risk Management
-
Aptevo Highlights APVO603: A Novel Bispecific Antibody Targeting 4-1BB and OX40 for Enhanced Solid Tumor Immunotherapy
-
Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post
-
Delinea Nears $400M, Demonstrating Strong Growth In Securing AI with Advanced Identity Security
-
Landsbankinn hf.: Covered bond exchange offering results
-
-
Surety One, Inc. Supporting Youth Achievement
-
IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025
-
Hill International Appointed as PMO Leader for Athens International Airport’s Airport Expansion Program
-
Spring Health Launches Neurodiversity Hub to Support Employees, Families, and Leaders
-
Ovation Mental Health Partners with Tennessee School of Beauty to Provide Comprehensive Mental Health Services
-
Aiosyn and Pramana Introduce Real-Time AI Processing for Kidney Biopsy Assessments
-
Wolters Kluwer expert on Community Reinvestment Act to speak at CBA LIVE national banking conference
-
KISS Products Unveils Exclusive WICKED-Inspired Nail and Lash Collections
-
Novotech Partners with Kyungpook National University Hospital to Strengthen Clinical Trial Capabilities in South Korea
-
CHO Plus Obtains U.S. Patent for Improved Production of Viral Vectors for Gene Therapy
-
SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately $
-
New Report Highlights 100+ Actionable Strategies for Climate-Resilient Water and Sanitation in Frontline Communities Across US
-
Buxton Takes Next Step in Revolutionizing Consumer Insights with Acquisition of Audiense
-
StepStone Group Announces 2025 Partner and Managing Director Promotions
-
Cytrellis Secures Health Canada and Saudi Food and Drug Authority Approval for ellacor® with Micro-Coring® Technology
-
Foresight Announces the Integration of NVIDIA Jetson Orin into its 3D Perception Systems
-
Europe’s Largest B2B Cannabis Conference Returns to Berlin in April 2025
-
New Research: 97% of Executives Feel Pressure to Maximize Revenue in the Next Two Years or They Risk Significant Consequences that Could Impact Bottom Lines
-
Madison Scientific Closes $7M in Seed Financing
-
Supply & Demand Chain Executive Honors LogicSource Leader, Erik Given, in the 2025 Pros to Know Awards
-
Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren's disease, has now receiv
-
TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead
-
Carhartt Unveils Inaugural "Steel Apple" Awards Celebrating Skilled Trades Educators Across America
-
Ankle & Foot Centers of America Offers Advanced Treatment Options for Fungal Toenail Infections
-
TPT Global Tech Super App Vume Live Announces Global Live Streams of Sports, News, and Entertainment Content
-
Labor Smart Inc. Expands Go Fast Energy with Q2 Direct-to-Consumer Growth Strategy
-
Ensysce Biosciences Announces PAINWeek 2025 Symposium and Recent Expert Panel Discussion on The State of the Nation in Pain
-
Electric Metals Presents Royal Ontario Museum with High-Grade Sample from its Emily Manganese Deposit in Minnesota
-
United States Antimony Corporation Announces Webcast set for Thursday, March 20, 2025, at 4:15 PM Eastern Time to Report Fiscal Year 2024 Financial and Operating Results
-
Ingest, Enhance, Deliver - Telestream Vantage Innovations Enable Bold Transformations at Scale
-
Grande Portage Resources Initiates Numerous Baseline Studies for the New Amalga Gold Project
-
E-3 Tech, LLC Acquires Sylvan Inc
-
Global Licensing Group Retail Programs Unlock Revenue Potential through Strategic Licensing Initiatives
-
INFUSE and HG Insights Bridge the Gap Between Intelligence and Activation With New Integrated Solutions
-
XTIUM Debuts as Unified Brand of ATSG and Evolve IP to Support Growing Demands of Modern Managed IT Services
-
Halvor Lines Accelerates Efficiency With Data-Driven Approach to Freight Operations
-
Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema
-
Bakkt Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
-
Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema
-
Impel Engages Brand Strategy and Innovation Firm Motto® to Support Growth
-
Global Hemp Group Announces Private Placement and Corporate Update
-
Bold Posts Updated Corporate Presentation
-
Blue Star's Target Series: Axis Prospect IP Chargeability Anomaly, Untested Orientation, Drill-Ready
-
Zodiac Gold Announces Closing of First Tranche of Non-Brokered Private Placement and Begins Mobilization for Infill Program
